We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Policy Roadmap Targets Opioid Addiction, Generics
FDA Policy Roadmap Targets Opioid Addiction, Generics
The FDA is prioritizing the opioid crisis, innovation, and generic competition in the coming year, the agency said in its 2018 Strategic Policy Roadmap.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor